Literature DB >> 12801888

Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-beta-induced nuclear accumulation.

Bernard A J Roelen1, Ori S Cohen, Malay K Raychowdhury, Deborah N Chadee, Ying Zhang, John M Kyriakis, Alessandro A Alessandrini, Herbert Y Lin.   

Abstract

Smad4, the common Smad, is central for transforming growth factor (TGF)-beta superfamily ligand signaling. Smad4 has been shown to be constitutively phosphorylated (Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin C-H, Miyazono K, and ten Dijke P. EMBO J 16: 5353-5362, 1997), but the site(s) of phosphorylation, the kinase(s) that performs this phosphorylation, and the significance of the phosphorylation of Smad4 are currently unknown. This report describes the identification of a consensus ERK phosphorylation site in the linker region of Smad4 at Thr276. Our data show that ERK can phosphorylate Smad4 in vitro but not Smad4 with mutated Thr276. Flag-tagged Smad4-T276A mutant protein accumulates less efficiently in the nucleus after stimulation by TGF-beta and is less efficient in generating a transcriptional response than Smad4 wild-type protein. Tryptic phosphopeptide mapping identified a phosphopeptide in Smad4 wild-type protein that was absent in phosphorylated Smad4-T276A mutant protein. Our results suggest that MAP kinase can phosphorylate Thr276 of Smad4 and that phosphorylation can lead to enhanced TGF-beta-induced nuclear accumulation and, as a consequence, enhanced transcriptional activity of Smad4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801888     DOI: 10.1152/ajpcell.00053.2003

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  26 in total

1.  Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

Authors:  Tawin Iempridee; Shreyasi Das; Iris Xu; Janet E Mertz
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 2.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.

Authors:  Qiang Ding; Tracy Luckhardt; Louise Hecker; Yong Zhou; Gang Liu; Veena B Antony; Joao deAndrade; Victor J Thannickal
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

Review 3.  Post-translational regulation of TGF-β receptor and Smad signaling.

Authors:  Pinglong Xu; Jianming Liu; Rik Derynck
Journal:  FEBS Lett       Date:  2012-05-19       Impact factor: 4.124

Review 4.  Regulation of Smad activities.

Authors:  Lan Xu
Journal:  Biochim Biophys Acta       Date:  2006-11-15

Review 5.  Posttranslational Regulation of Smads.

Authors:  Pinglong Xu; Xia Lin; Xin-Hua Feng
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-12-01       Impact factor: 10.005

Review 6.  New Player in Endosomal Trafficking: Differential Roles of Smad Anchor for Receptor Activation (SARA) Protein.

Authors:  Victoria Rozés-Salvador; Sebastian O Siri; Melina M Musri; Cecilia Conde
Journal:  Mol Cell Biol       Date:  2018-11-28       Impact factor: 4.272

Review 7.  To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications.

Authors:  Katharine H Wrighton; Xin-Hua Feng
Journal:  Cell Signal       Date:  2008-02-15       Impact factor: 4.315

8.  Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2.

Authors:  Min Liang; Yao-Yun Liang; Katharine Wrighton; Dana Ungermannova; Xiao-Ping Wang; F Charles Brunicardi; Xuedong Liu; Xin-Hua Feng; Xia Lin
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

9.  Human SMAD4 is phosphorylated at Thr9 and Ser138 by interacting with NLK.

Authors:  Yan Shi; Kan Ye; Huiling Wu; Yixing Sun; Huili Shi; Keke Huo
Journal:  Mol Cell Biochem       Date:  2009-08-19       Impact factor: 3.396

10.  Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes.

Authors:  Guillemette Ramey; Jean-Christophe Deschemin; Sophie Vaulont
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.